z-logo
open-access-imgOpen Access
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Author(s) -
Diana Matheoud,
Ayumu Sugiura,
Angélique BellemarePelletier,
Annie Laplante,
Christiane Rondeau,
Magali Chemali,
Ali Fazel,
John Bergeron,
LouisÉric Trudeau,
Yan Burelle,
Étienne Gag,
Heidi M. McBride,
Michel Desjardins
Publication year - 2016
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2016.05.039
Subject(s) - parkin , pink1 , mitophagy , biology , autophagy , microbiology and biotechnology , antigen presentation , mitochondrion , immune system , antigen , cross presentation , immunology , disease , parkinson's disease , genetics , apoptosis , t cell , pathology , medicine
Antigen presentation is essential for establishing immune tolerance and for immune responses against infectious disease and cancer. Although antigen presentation can be mediated by autophagy, here we demonstrate a pathway for mitochondrial antigen presentation (MitAP) that relies on the generation and trafficking of mitochondrial-derived vesicles (MDVs) rather than on autophagy/mitophagy. We find that PINK1 and Parkin, two mitochondrial proteins linked to Parkinson's disease (PD), actively inhibit MDV formation and MitAP. In absence of PINK1 or Parkin, inflammatory conditions trigger MitAP in immune cells, both in vitro and in vivo. MitAP and the formation of MDVs require Rab9 and Sorting nexin 9, whose recruitment to mitochondria is inhibited by Parkin. The identification of PINK1 and Parkin as suppressors of an immune-response-eliciting pathway provoked by inflammation suggests new insights into PD pathology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom